Bill & Melinda Gates Foundation Sera Prognostics, Inc. Transaction History

Bill & Melinda Gates Foundation

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.2 - $3.62 $959,776 - $2.9 Million	-799,814 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.96 - $8.8 $59,200 - $176,000	20,000 Added 2.56%	799,814 $3 Million
Q3 2021 Nov 15, 2021	BUY	$7.9 - $13.04 $6.16 Million - $10.2 Million	779,814 New	779,814 $8.7 Million

20.3M

120K

Ticker SERA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 29,596,900
Market Cap $201M
Description
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...

Get notified when there are updates to the investment portfolio of Bill & Melinda Gates Foundation, based on Form 13F filings with the SEC.

Stay updated on Bill & Melinda Gates Foundation with notifications on news.